VEGFA and neoplasm: TME participates in regulating neo‐angiogenesis, tumor invasive growth, and response to treatments, and also serves as a target for medical therapies, such as immune checkpoint inhibitors (ICIs), monoclonal antibodies directed against the epithelial growth factors (EGF) and against vascular endothelial growth factor (VEGF).9